Wird geladen...

Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under Research

The increasing prevalence of allergic diseases demands efficient therapeutic strategies for their mitigation. Allergen-specific immunotherapy (AIT) is the only causal rather than symptomatic treatment method available for allergy. Currently, AIT is being administered using immune response modifiers...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccines (Basel)
Hauptverfasser: Johnson, Litty, Duschl, Albert, Himly, Martin
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2020
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7349961/
https://ncbi.nlm.nih.gov/pubmed/32443671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8020237
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!